Skip to main content
Homepage
Full 18-step deep-dive · ~20–30 min · a member feature.
AGING Analysis Report
Aug 3, 2026
20 days ago · 100% complete
NOT DEPENDABLE This report predates a filing — its financial basis has been replaced.
Report generated: Aug 3, 2026 · Filing on record since: Aug 19, 2026 · 16 days after
For AI assistants & researchers — machine-readable summary of this page

What this page is: Delvantic's full research page for Citigroup Inc. (C) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.

Our current read (analysis of 2026-08-23): Designation Low · Gem Score -32 (−100…+100 Quality+Value blend) · Quality 16 · Value -72 · Sentiment 28 (timing only, not weighted) · Composite fair value $114.63 vs $132.45 at analysis

Page map (sections in order; each card carries a stable reference-name attribute you can cite):

  • profile-header / price-overview — company profile, live quote, market cap
  • extended-analysisthe core: three AI lens reads with findings, scores, and the analyst memo
  • future-predictions — our forward price-band predictions
  • market-narrative / ai-findings / gpt-critique — narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)
  • Members-only sections (render as login gates for anonymous readers): price-history, income-trend, key-metrics, financials (statement tables), insider-trading. The analysis above is public; the raw data tables require a free account.

More for machine readers: site briefing at /llms.txt · any ticker resolves at delvantic.com/stock/TICKER · raw inputs are public-company filings and market data (via licensed data feeds); every model, score, lens read, and prediction on this page is Delvantic's own analysis.

Citigroup Inc.

C NYSE
Financial Services · Banks - Diversified
New York, NY 10013, United States citigroup.com Updated Aug 3, 12:15am
Price
$132.45
Market Cap
$222.2B
Employees
219,000
Beta
1.09
Avg Volume
13,743,593
Last Dividend
$2.40
CEO
Ms. Jane Nind Fraser Ph.D.

Citigroup Inc. is a global holding company that provides a comprehensive array of financial products and services to consumers, corporations, governments, and institutions worldwide. It operates through key segments including Services, which encompasses treasury and trade solutions, securities services, and agency securities lending; Markets, offering investment banking, equities, fixed income, currencies, commodities trading, and hedging; Banking, focused on corporate lending, commercial banking, and capital markets origination; Wealth, delivering private banking, investment management, and wealth advisory; and U.S., providing personal banking, credit cards, and retail services. Citigroup Inc. supports diverse clients with digital platforms, global transaction services, and risk management solutions, playing a pivotal role in facilitating international trade, capital flows, and wealth preservation in major financial markets. Founded in 1812 and headquartered in New York, New York, it stands as a cornerstone of the diversified banking sector.

Runs with full report Generated: Aug 3, 2026 12:13am
Price Overview
Price at report time
$132.45
as of Aug 3, 12:23am (20d ago)
Change · Aug 3
+0.13 (+0.10%)
Day Range
$131.94 – $135.44
52-Week Range
$87.94 – $147.96
50-Day MA
$135.15
200-Day MA
$118.80
Volume
9,604,000.00
Right now · live
Log in to get the live feed
Members see the real-time price and the move since this report (over 20d).
Share Structure
Outstanding 1,677,400,000.00
Float 1,672,535,540.00
Free Float 99.7%
High free float — 99.7% of shares trade freely, ~0.3% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Aug 3, 2026 12:23am (20d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jul 30, 2026 1:42pm (24d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
TD Twelve Data statement HEX SEC filing
Industry comparison last run: Aug 3, 2026 12:10am
P/E Ratio (Price per dollar of earnings)
HEX
Stock Price / EPS (Diluted)
18.95
Stock Price: $132.45
EPS (Diluted): 6.99
P/B Ratio (Price vs net asset value)
HEX
Stock Price / Book Value Per Share
1.27
Stock Price: $132.45
Total Equity: $213.82B
Shares: 2,046,638,054
EV/EBITDA (Total value vs operating profit)
HEX
Enterprise Value / EBITDA
Market Cap: $222.17B
Total Debt: $367.71B
Cash: $349.58B
EBITDA: N/A
EBITDA not available
Enterprise Value (Takeover price (cap + debt - cash))
HEX
Market Cap + Total Debt - Cash
$260.8B
Market Cap: $222.17B
Total Debt: $367.71B
Cash: $349.58B
Gross Margin (Revenue left after direct costs)
HEX
Gross Profit / Revenue
Gross Profit: N/A
Revenue: $85.21B
Missing from API: Gross Profit
Operating Margin (Revenue left after all operations)
HEX
Operating Income / Revenue
Operating Income: N/A
Revenue: $85.21B
Missing from API: Operating Income
Net Margin (Revenue left as actual profit)
HEX
Net Income / Revenue
16.8%
Net Income: $14.31B
Revenue: $85.21B
ROE (Profit from shareholder equity)
HEX
Net Income / Total Equity
6.7%
Net Income: $14.31B
Total Equity: $213.82B
ROIC (Profit from all invested capital)
HEX
NOPAT / Invested Capital
Operating Income: N/A
Tax Rate: 27.1%
Equity: $213.82B
Total Debt: $367.71B
Cash: $349.58B
Missing from API: Operating Income
Current Ratio (Can it pay short-term bills)
HEX
Current Assets / Current Liabilities
Current Assets: N/A
Current Liabilities: N/A
Missing from API: Current Assets, Current Liabilities
Debt/Equity (Leverage — debt vs equity)
HEX
Total Debt / Total Equity
1.72
Short-Term Debt: $51.88B
Long-Term Debt: $315.83B
Total Debt: $367.71B
Total Equity: $213.82B
Rev/Share (Top-line per share)
HEX
Revenue / Shares Outstanding
$41.64
Revenue: $85.21B
Shares: 2,046,638,054
Book Value/Share (Net assets per share)
HEX
(Total Assets - Total Liabilities) / Shares
$104.47
Total Equity: $213.82B
Shares: 2,046,638,054
FCF/Share (Real cash generated per share)
HEX
(Operating Cash Flow + CapEx) / Shares
$-36.23
Operating CF: -$67.63B
CapEx: -$6.52B
Shares: 2,046,638,054
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
TD
Last Annual Dividend / Stock Price
1.8%
Last Dividend: $2.40
Stock Price: $132.45
Payout Ratio (Earnings paid out as dividends)
HEX
Dividends Paid / Net Income
37.6%
Dividends Paid: -$5.37B
Net Income: $14.31B
Industry Benchmarks
Last run: Aug 3, 2026 12:10am
Compares C against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Income Statement (Annual)
Last updated: Jul 30, 2026 1:42pm (24d ago)
Metric 2021 2022 2023 2024 2025
Revenue $71.9B $75.3B $78.5B $81.1B $85.2B
Cost of Revenue
Gross Profit
Operating Expenses $26.7B $28.3B $30.7B $29.7B $30.8B
Operating Income
Net Income $22.0B $14.8B $9.2B $12.7B $14.3B
EBITDA
EPS $10.80 $7.04 $4.07 $6.03 $7.11
EPS (Diluted) $10.14 $7.00 $4.04 $5.94 $6.99
Balance Sheet (Annual)
Last updated: Jul 31, 2026 9:16am (23d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $262.0B $342.0B $260.9B $276.5B $349.6B
Total Current Assets
Total Assets $2.3T $2.4T $2.4T $2.4T $2.7T
Current Liabilities
Long-Term Debt $254.4B $271.6B $286.6B $287.3B $315.8B
Total Liabilities $2.1T $2.2T $2.2T $2.1T $2.4T
Total Equity $202.7B $201.8B $206.3B $209.4B $213.8B
Retained Earnings $184.9B $194.7B $198.9B $206.3B $215.1B
Cash Flow (Annual)
Last updated: Jul 30, 2026 1:42pm (24d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $61.2B $25.1B -$73.4B -$19.7B -$67.6B
Capital Expenditure -$4.1B -$5.6B -$6.6B -$6.5B -$6.5B
Free Cash Flow $57.1B $19.4B -$80.0B -$26.2B -$74.2B
Acquisitions (net)
Net Debt Issued / (Repaid) -$4.3B $47.7B $860.0M $6.1B $18.7B
Dividends Paid -$5.2B -$5.0B -$5.2B -$5.2B -$5.4B
Stock Buybacks -$7.6B -$3.3B -$2.0B -$2.5B -$13.3B
Net Change in Cash -$47.6B $80.0B -$81.1B $15.6B $73.0B
Growth Trends (YoY %)
Last updated: Jul 30, 2026 1:42pm (24d ago)
Metric 2022 2023 2024 2025
Revenue Growth +4.8% +4.2% +3.3% +5.1%
Gross Profit Growth
Operating Income Growth
Net Income Growth -32.4% -37.8% +37.4% +12.8%
EBITDA Growth
Dividend History (Last 20)
Last updated: Jul 31, 2026 9:17am (23d ago)
Date Dividend Declaration Record Payment
2026-05-04 $0.60
2026-02-02 $0.60
2025-11-03 $0.60
2025-08-04 $0.60
2025-05-05 $0.56
2025-02-03 $0.56
2024-11-04 $0.56
2024-08-05 $0.56
2024-05-03 $0.53
2024-02-02 $0.53
2023-11-03 $0.53
2023-08-04 $0.53
2023-04-28 $0.51
2023-02-03 $0.51
2022-11-04 $0.51
2022-07-29 $0.51
2022-04-29 $0.51
2022-02-04 $0.51
2021-10-29 $0.51
2021-07-30 $0.51
0Company Classification 1Industry Landscape 2Company Momentum 3Forward Projection 4aDCF Valuation 4bEarnings Power Value 4cAnchored PE 4dReverse DCF 4eRevenue-Based DCF 4fAnchored P/S 4gScenario Analysis 4hDividend Discount Model 4iBook Value Analysis 4jInsider Activity 4fCash Flow Quality 4gDebt Maturity Risk 4hMacro Environment 4iSector Intelligence 4jRevenue Confidence 4kSensitivity Analysis 4lSector Demand Cycle 5AI Investigation 5bThesis Evaluation 6Valuation Synthesis
computed not applicable not yet run 14 computed · 6 not applicable · 4 not yet run
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for C — it's generated by the pipeline (market-narrative step).
Claude Reading
Independent analyst synthesis · claude-opus-4-7 · generated 2026-08-03 00:22:43
Verdict Modestly overvalued — fair value $110-118 based on 8% normalized ROE at 1.0-1.1x TBV; Q4 2025 margin collapse to 12.4% undermines the turnaround premium and I'd wait for a pullback to ~$115 or a clean Q1 2026 print before adding.

The raw numbers tell a more nuanced story than "fully priced turnaround." Q1-Q3 2025 showed genuine operating leverage: revenue held ~$21.6-22.1B with net income running $3.75-4.06B (17-18.8% margins), a real step-up from 2024's $3.2-3.4B/16% cadence. Then Q4 2025 collapsed to $19.87B revenue and $2.47B NI (12.4% margin) — sequentially worse than Q4 2024's $2.86B. That's not seasonal noise dressed up; that's a genuine deceleration into year-end, and it's exactly what the "Revenue Confidence: decelerating" flag is picking up. Full-year 2025 NI of $14.31B on $85.21B revenue is a legitimate 13% earnings beat over 2024, but the exit-run rate suggests 2026 consensus needs to come down, not up. At $132.45 and 18.9x trailing P/E, you're paying peer multiples (JPM ~14x, BAC ~14x, WFC ~14x) for the worst ROE in the group at 6.69%.

The bank-specific caveats deserve more weight than the models gave them. Operating CF of -$67.6B and FCF of -$74.2B are meaningless for a bank — those reflect trading book and loan portfolio movements, not earnings quality. The "Poor Cash Flow Quality" flag and the synthesis warning that "reported earnings may not reflect reality" are misapplied here; for a diversified bank, NI and ROE are the honest metrics, and NI is real. That said, ROE of 6.69% versus JPM's ~17% and BAC's ~9% is the actual damning number. Citi earns roughly its cost of equity in a benign credit environment with the yield curve un-inverted — this is as good as it gets cyclically, and returns are still subscale. The 1.27x P/B (roughly 0.9x tangible book after adjusting for ~$25B goodwill) is where the market's real verdict lives, not the P/E.

I largely agree with the synthesis fair value near $110 but for different reasons than the model. The DCF anchor is doing the wrong work — for a bank, normalize on ROE × book. At sustained 8% ROE (a realistic 2026-27 outcome if transformation continues) on ~$104/share tangible book, and applying a 1.0-1.1x TBV multiple (peer-appropriate for that return level), you get $104-115. The current $132.45 embeds ~10% ROE by 2027 — Fraser's stated target, but she's been at this since March 2021 with the number still stuck at 6-7%. The thesis evaluation score of -8 (bear-tilted) feels directionally right; the Market Forces "value trap" framing is too harsh given the earnings growth is real, but the "losing share in a booming industry" point is correct — investment banking peers grew faster in 2025.

The contrarian case worth taking seriously: rates normalization plus continued expense discipline could push 2026 NI to $16-17B, and if the market grants 12x on that with a modest TBV re-rate to 1.1x, you get $140-150. But that requires Q4's weakness to be one-off (unproven), Markets revenue to recover (structurally subscale per bears), and the transformation to actually finish. Insider data is useless — only routine award grants dated 2026-07-01, no open-market buying signal. The Q4 miss is the tell: at $132 you're paying for execution that just wobbled visibly. I dissent modestly from the synthesis's -17% downside — I think fair value is $110-118, so downside is closer to -12%, and the asymmetry isn't compelling either direction until we see Q1 2026. This is a hold-if-owned, don't-chase-if-not situation, and if forced to lean, the Q4 print says trim.

GPT Reading
Independent reading · gpt-5.4 · generated 2026-08-03 00:22:57
Verdict Overvalued at $132.45 — fair value is closer to $110-$115 unless Citi can lift ROE meaningfully above the current 6.7% and make $4B-plus quarterly earnings the norm.

At $132.45, Citi is being asked to wear a quality multiple without delivering quality returns. The core numbers are better than the old “broken bank” caricature, but not good enough to justify nearly 19x earnings and 1.27x book on a 6.7% ROE. Revenue has improved steadily — $71.9B in 2021 to $85.2B in 2025, about 4% annualized — and net income recovered from the weak 2023 base of $9.2B to $14.3B in 2025. But that “recovery” mostly gets you back to roughly 2022 earnings of $14.9B and still far below 2021’s $22.0B. The market cap of $222B implies investors are paying up as if Citi is already on a path to double-digit sustainable returns; the actual annual earnings yield here is only about 6.4%, which is not compelling for a globally systemic bank with middling profitability and obvious execution demands.

The quarterly pattern reinforces that this is a decent-but-not-great earnings machine, not a proven transformation winner. Through the first three quarters of 2025, revenue ran $21.6B, $21.7B, and $22.1B, with net margins climbing to 18.8%, 18.5%, and 17.0%; then Q4 fell back to $19.9B revenue and just $2.47B of net income, a 12.4% margin. Some seasonality and episodic costs are normal in banking, but when a turnaround story deserves a premium, I want to see cleaner evidence of operating leverage and a more durable margin profile. Instead, what I see is a bank whose revenues are stable enough, but whose earnings power still oscillates too much relative to the valuation being paid. If Citi were trading around book or a bit below, this variability would be tolerable. At a notable premium to book with ROE still subpar, it is not.

The biggest trap in the data is to over-penalize the cash flow statement. Operating cash flow of negative $67.6B and free cash flow of negative $74.2B look ugly, but for a bank those figures are heavily distorted by deposit, loan, and balance-sheet movements; I do not think “negative FCF” is the decisive bear point. The decisive bear point is simpler: equity of $213.8B is supporting only $14.3B of earnings. That 6.7% return on equity is weak, full stop. A strong global bank trading at 1.27x book should be showing something closer to 10%-12%+ through-cycle returns or have a very clear, near-dated bridge to them. The balance sheet itself is not the issue — debt of $367.7B against $349.6B cash is normal enough in banking context — but the capital is not yet earning enough. The stock is priced for a rerating that the reported profitability has not earned.

The best counterargument is that the direction of travel is undeniably better. Annual net income has risen from $9.2B in 2023 to $12.7B in 2024 and $14.3B in 2025, while revenue rose 5.1% year over year in the latest annual comparison. Quarterly net income in 2025 was higher than 2024 in every quarter, and Q1-Q3 2025 all printed above $4.0B, versus $3.2B-$3.4B in the comparable 2024 periods. That is real progress. If management can convert that into sustained quarterly earnings of roughly $4B+ with fewer cleanup charges and keep revenue in the $85B-$90B range, today’s multiple could compress quickly on forward earnings. On that view, the market is not paying for current 6.7% ROE but for a credible move toward something much better. I weigh that less heavily because the current data still show a bank needing the future to justify the present price, and banks that require flawless multi-year execution usually should not command premium valuations before the returns actually show up.

What would change my mind is not another quarter of okay revenue; it is proof of structurally better returns. If Citi can deliver annual net income above $18B without a materially larger equity base — implying ROE moving toward 8.5%-9% as an intermediate step — and hold quarterly net margins mostly in the high teens rather than dropping to 12%-14% in weaker quarters, the stock would deserve more benefit of the doubt. More specifically, I would want to see at least two to three consecutive quarters with revenue above $21B and net income above $4B, plus evidence that 2026 is tracking materially above 2025’s $14.3B. Absent that, the current price looks like investors are paying in advance for a transformation that remains only partially visible in the reported numbers.

Grok Reading
Independent reading · grok-4.5 · generated 2026-08-03 00:23:21
Verdict Overvalued at $132.45 vs ~$110 fair value; low-ROE bank priced for a turnaround not yet in the numbers

The numbers tell a story of a bank that has clawed earnings back from the 2023 trough but has not earned the multiple the market is assigning. Full-year 2025 revenue of $85.21B is only 5.1% above 2024’s $81.09B and sits on a 4.2% five-year CAGR—respectable for a mega-bank, yet nowhere near enough to justify a 18.9x trailing P/E or a 1.27x price-to-book when ROE is still a dismal 6.7%. Net income of $14.31B looks better than 2023’s $9.23B and even edges 2024’s $12.68B, but it remains 35% below the 2021 peak of $21.95B. The sequential picture is worse: Q4 2025 revenue collapsed to $19.87B with net margin compressing to 12.4% from the 17–18.8% range that prevailed through the first three quarters. That is not the clean trajectory a turnaround premium requires.

Balance-sheet optics are mixed and cash-flow optics are ugly. Equity of $213.82B against $367.71B of debt produces a 1.72 debt-to-equity ratio that is normal for the sector, and the near-match of cash ($349.58B) to debt keeps net leverage manageable. Yet operating cash flow of –$67.63B and free cash flow of –$74.15B flag poor earnings quality even after allowing for the usual bank balance-sheet noise. A 1.8% dividend yield funded at a 37.5% payout is sustainable only if the earnings base holds; the Q4 margin drop already tests that assumption. Insider activity is pure award noise—no open-market conviction either way.

I therefore read the stock as overvalued at $132.45. The prior models’ composite fair value near $110 is directionally correct: a mid-single-digit ROE franchise does not deserve a 19x earnings multiple or a 20% premium to tangible book while revenue growth decelerates and cash conversion stays negative. The market is paying for Jane Fraser’s cost-cut and simplification story before the income statement has delivered peer-level returns.

The strongest counter-argument is the earnings momentum itself. Net income CAGR of 24.5% and the 12.8% year-over-year lift in recent earnings show real operating leverage is appearing; if the Services franchise continues to scale and the announced $2–3B of cost saves land cleanly, ROE could climb toward 10–12% within two years and retroactively justify today’s multiple. Activists and sell-side turnaround notes lean on exactly that path, and a bank trading only 1.27x book is not priced for perfection in absolute terms. I weigh this less heavily because the same data show revenue defense already fraying (Q4 drop, lagging sector peers) and because banks that promise ROE expansion rarely receive the full multiple re-rating until the ROE is visible in the rear-view mirror—not priced in advance.

I would flip to neutral or constructive only on two concrete prints: a sustained ROE print above 10% for two consecutive quarters, or full-year 2026 revenue growth re-accelerating above 7% with net margins back above 17% and no further sequential revenue decline. Either would confirm the transformation is converting into durable economics rather than one-time cost optics.

Big-3 Panel — where each AI stands
Each AI above independently stated a direction (undervalued, fairly valued, or overvalued) and how strongly it believes it (conviction, 0–5). We combine those into a Bull-Bear Index on a 0–10 scale: 5 is neutral, 10 is maximum bullish (undervalued at full conviction), 0 is maximum bearish. We compute the score ourselves with the same arithmetic for every seat — the models never grade their own bullishness — so the three are directly comparable. Δ shows how far each seat sits from the panel average of 1.3; a large Δ marks the dissenting voice, usually the one worth reading.
Claude claude-opus-4-7 2.0
overvalued · conviction 3/5 · Δ +0.7 vs panel · self: 4.0
GPT gpt-5.4 1.0
overvalued · conviction 4/5 · Δ -0.3 vs panel · self: 3.0
Grok grok-4.5 1.0
overvalued · conviction 4/5 · Δ -0.3 vs panel · self: 3.0
Advanced Analysis Forensic deep-dive · separate lenses
Separate reads — Company Quality (is it a great business?), Valuation (is it mispriced?), and General Sentiment (how macro + narrative are pushing it), kept deliberately apart · 2026-08-03 00:32:23
Delvantic - Cairn AI
Quality — wait for a dip 7/10
Great franchise recovery, but at $132 the turnaround is already in the tape — I wait, I don't chase.
The cruxWhether Citi can drive normalized ROE above ~8% to justify a price above tangible-book premium; until that shows up in prints, $110 is deserved, not $132.
Forensic checks Derived mechanically from C's filed financials — not from the AI lenses
Liquidity & RunwayLong Runway
DilutionShare Count Shrinking
Earnings QualityWeak — Some Red Flags
The four lensesswitch a tab for its full read — score + evidence
Company Quality
+16
Solid
edge √Σ 82 · risk √Σ 65 · conf 6/10

Citigroup shows a steady top-line recovery from $71.9B (2021) to $85.2B (2025), with net income rebounding from the 2023 trough of $9.2B to $14.3B in 2025. Diluted shares have edged down from 2.16B to 2.05B (roughly -1.4% CAGR), so per-share value is being concentrated rather than diluted — a discipline point in the bank's favor. Insider activity is award-heavy with modest sales and zero open-market buys; nothing directional either way.

Strengths 3
m55
Earnings recovery + revenue growth
Revenue up 18.5% cumulative 2021-2025 ($71.9B to $85.2B); net income recovered from $9.2B (2023) to $14.3B (2025), suggesting the restructuring is bearing fruit.
m45
Share count shrinking
Diluted shares down from 2.16B (2021) to 2.05B (2025), -1.4% CAGR. Management is a net buyer, protecting per-share value.
m40
Scale and systemic status
$349B liquid cash and G-SIB status provide franchise durability; deposit funding base is a structural moat.
Concerns 4
m45
Middling profitability
Net income of $14.3B on revenues of $85.2B is a ~17% net margin — respectable but well below best-in-class peers, and ROA remains thin for the asset base.
m35
Earnings volatility signals uneven execution
Net income swung from $22.0B (2021) to $9.2B (2023) back to $14.3B (2025) — indicates the franchise is still working through legacy issues and restructuring.
m20
Forensic modules flag distress (with caveat)
Altman Z of 0.2 and OCF/NI of -1.95x look alarming but are largely artifacts of applying industrial models to a bank; still worth noting that standard earnings-quality screens do not clear this name.
m25
No insider conviction buying
11 sales totaling $23M vs. zero open-market buys in the last 12 months; recent tape is all A-Awards. No insider is signaling personal conviction.
This is a competent, improving mega-bank rather than either a fortress or a wreck. The forensic module flags (Altman Z distress, negative FCF) are noise for a bank of this type and should not drive the quality read. What matters is that revenues are growing, earnings recovered from a real 2023 dip, and the share count is being managed down. What holds it back from a higher grade is that Citi's returns still lag the best-run US banks and the franchise has been in perpetual restructuring for a decade. Solid, not strong.
Verify before trusting this (6)
  • CET1 ratio and regulatory capital trajectory in the latest 10-Q/K
  • Progress on restructuring/divestitures (Banamex, exits of consumer businesses) and associated one-time charges
  • Net interest margin trend and credit loss provisioning
  • Efficiency ratio vs. peer banks (JPM, BAC, WFC)
  • Any consent orders or regulatory remediation costs still outstanding
  • Buyback authorization size and pace relative to earnings
Valuation / Mispricing
-72
Rich
edge √Σ 25 · risk √Σ 116 · conf 7/10
Price $132.45 vs deserved ~$110 - roughly 20% overpriced, negative margin of safety. attractive below $105.00

The e2e composite fair value is $110.39 and the signal-adjusted FV is $109.95, both well below the $132.45 price - implying about -17% downside rather than upside. The anchored-PE cross-check lands at the same $110 level, so this isn't a single runaway method; multiple lenses converge on a deserved price in the $108-112 zone. The earnings-quality haircut (weak, some red flags) argues for the lower end of that range, not the higher.

Cheap signals 1
m25
Business quality is improving
Solid quality grade, shrinking share count, and recovering earnings support a deserved value at the upper end of the $108-112 band - but not above $130.
Rich / priced-in 4
m72
Price ~20% above composite FV
Composite FV $110.39 and signal-adjusted FV $109.95 vs $132.45 price - a clear premium, not a discount, across converging methods.
m60
Anchored-PE corroborates the gap
The PE-anchored value also sits at $110.39, so the overvaluation isn't a DCF artifact - it's what a peer-multiple lens says too.
m55
Turnaround already priced in
Narrative flags a 20%+ premium reflecting confidence in Fraser's restructuring; the market is paying today for an ROE recovery that hasn't been delivered.
m40
Earnings quality argues for a haircut, not a premium
The forensic signal flags weak earnings quality (score -1), which should pull deserved value down, yet the stock trades above the un-haircut FV.
I can't call this cheap with a straight face. Every valuation lens I have puts deserved value near $110, and I'm paying $132 - that's a negative 20% margin of safety on a bank whose ROE still trails peers and whose earnings quality just got flagged. The business is genuinely getting better, but the market has already written the turnaround check. I'd need to see this under $110, ideally closer to $100, before the risk/reward gets interesting - buying a mid-tier money-center bank at a premium to fair value is not a game I want to play.
Verify before trusting this (5)
  • Forward ROE trajectory in the next 2-3 quarters vs the ~11-12% peer bar implied by the multiple
  • Expense run-rate and severance charges - is cost-out actually landing in the P&L?
  • Services and Wealth segment growth and margins - the parts the bull case leans on
  • Any one-time gains or DTA effects inflating recent EPS
  • Regulatory capital requirements post-Basel endgame that could constrain buybacks
General Sentiment
+28
Tailwind
tail √Σ 85 · head √Σ 56 · conf 6/10

The tape is mildly constructive (regime +22, VIX 16, S&P barely off highs) and Citi's 1.09 beta means it participates without being whipped. More importantly, the active narrative on this name is a fallen-angel turnaround under new leadership - moderate intensity, moderate durability - and the recent flow (Zacks Strong Buy addition, Strong Buy income list inclusion on July 31) directly reinforces that story rather than fighting it. Analyst tone toward the money-center cohort is warming as the Fed's higher-for-longer stance is being framed as an NII tailwind (JPM piece), and Citi rides that coattail even without being the headline name.

Tailwinds 4
m55
Fallen-angel narrative in the sweet spot
Turnaround story has moderate intensity and durability - enough to keep bid interest but not so consensus that it is exhausted. The 20% premium to DCF shows the market is already leaning in, and durability means dips get bought.
m45
Fresh Strong Buy tags and income-stock inclusion
Zacks added C to both the Strong Buy list and the income buy list on July 31. That is exactly the kind of low-key sell-side flow that pulls yield-seeking and rotation capital into a name whose story is 're-rating candidate.'
m35
Higher-for-longer framed as bank-positive
News flow around the Fed's hawkish pause is being spun as an NII tailwind for money-center banks. Citi is not the lead beneficiary (JPM is), but the sector read-through is a mild positive rather than the rate-shock headwind banks faced in prior cycles.
m30
Calm, mildly risk-on tape suits a 1.09 beta re-rating story
VIX 16, index near highs, regime score +22. Turnaround names need a stable tape to let the story compound in price; a risk-off jolt would have hit this cohort hardest, and that jolt is not here.
Headwinds 3
m40
Story is priced - premium leaves little room for slips
Price is ~20% above DCF fair value, meaning sentiment is already leaning bullish. Any execution stumble or a crack in the turnaround narrative gets punished harder than in a name where expectations are on the floor.
m30
Structural comparison risk vs JPM/GS
The bear frame - slower digital, legacy costs, regulatory overhang - is dormant not dead. Peer earnings that flatter JPM (as the recent piece does) implicitly widen the perceived gap and can reawaken the 'why own Citi over JPM' debate.
m25
Macro cross-current: rates 4.68%, market PE 26.9
Elevated multiples and sticky long rates are a broad equity headwind. Citi's beta means it feels it, but banks are less multiple-sensitive than growth, so the pressure is real but muted for this specific name.
Net pressure leans positive but not decisively. The turnaround narrative is doing real work here - moderate but durable, freshly reinforced by Strong Buy tags and a benign tape - and Citi's beta is high enough to participate in a calm-to-constructive market without being punished. The counterweight is that sentiment is already leaning in (20% premium to fair value) and any peer-comparison moment favors JPM, not Citi. Call it a genuine but modest tailwind: the story is being bought, but it is not a mania and it is not bulletproof.
Verify before trusting this (4)
  • Any commentary from Citi management or peers that reframes the turnaround pace - a miss on cost targets would crack the fallen-angel narrative fast
  • Whether the buy-side rotation into money-center banks broadens beyond JPM to include Citi in coverage upgrades
  • VIX above 20 or a sharp curve move - would flip the tape from supportive to hostile for a 1.09-beta re-rating story
  • Sell-side target revisions post next print - the premium to DCF needs analyst validation to hold
The market-wide tape + this name's exposure to it (beta / sector / narrative durability). Context on the non-fundamental pressure — not a call on the business or the price. processId: detail-general-sentiment
Growth Outlook
not run

This lens hasn't been run for this ticker yet.

The forward growth verdict — is the business itself likely to grow (next 2 quarters / year 1 / years 2–3), judged against its category and against printed expectations. The full horizon ladder + creme renders on the Growth Outlook card above. Not a call on the price (Valuation owns that) or the tape (Sentiment owns that).
Please log in to view trade setups
The Augustus trade-setup read is a members feature.
Log in
Lenses kept deliberately separate — Company Quality (price-agnostic), Valuation (price-conditional), General Sentiment (non-fundamental macro/narrative pressure), and Growth Outlook (the forward growth verdict). The scores are not blended. Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Price Prediction
Lower -9.4% v0.6.0 View full prediction →

When we made this prediction on Aug 3, 2026, C was $132.45. We expect it to be $120.00 by Feb 2027, and we consider it great value under $105.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 3, 2026.

Price when predicted$132.45
Our estimate for Feb 2027$120.00-9.4%
Great value below$105.00
Price history shown (6 Months)

Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.

Community AI Feedback
No community reviews yet for C. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
v1.1.562 · 9b2927c4 · 2026-08-22 16:52:06